Concepedia

Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up

Olimpia Longo, Antonella Tripiciano, Valeria Fiorelli, Stefania Bellino, Arianna Scoglio, Barbara Collacchi, Maria Josefina Ruiz Alvarez, Vittorio Francavilla, Angela Arancio, Giovanni Paniccia,

Vaccine · 2009 · 54 citations · 21 references

DOI

Concepts

References

21

<i>Trans</i> -Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III)

Suresh K. Arya, Chan Guo, Steven F. Josephs et al. · Science · 1985 · 863 citations

, , +17

Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation

Barbara Ensoli, Luigi Buonaguro, Giovanni Barillari et al. · Journal of Virology · 1993 · 794 citations · Full text

, , +11

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

Todd M. Allen, David H. O’Connor, Peicheng Jing et al. · Nature · 2000 · 680 citations · Full text

, , +15

The trans-activator gene of HTLV-III is essential for virus replication

Amanda G. Fisher, Mark B. Feinberg, Steven F. Josephs et al. · Nature · 1986 · 628 citations

, , +14

The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals

Marylyn M. Addo, Marcus Altfeld, Eric Rosenberg et al. · Proceedings of the National Academy of Sciences · 2001 · 188 citations · Full text

, , +17